Shiyu Capital
19
77M
16
1.90
7
0.16
- Stages of investment
- Areas of investment
Summary
Shiyu Capital is the famous VC, which was founded in 2014. The main department of described VC is located in the Beijing. The venture was found in Asia in China.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Shiyu Capital, startups are often financed by Stone Capital, H&Q Asia Pacific. The meaningful sponsors for the fund in investment in the same round are Legend Capital, Zhuhai Huajin Asset, State Development & Investment Corporation (SDIC).
We can highlight the next thriving fund investment areas, such as Medical, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Biotheus. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The current fund was established by Calvin Cao, Hongbing Yang. Besides them, we counted 2 critical employees of this fund in our database.
The fund is constantly included in 2-6 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund. Considering the real fund results, this VC is 37 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Shiyu Capital is 500 millions - 1 billion dollars. The top activity for fund was in 2019.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 7
- Rounds per year
- 1.90
- Follow on index
- 0.16
- Investments by industry
- Health Care (11)
- Biotechnology (8)
- Pharmaceutical (5)
- Medical (4)
- Therapeutics (3) Show 14 more
- Investments by region
-
- China (19)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 34M
- Group Appearance index
- 0.95
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Chrono24 | 13 Aug 2019 | E-Commerce, Lifestyle, Marketplace, Fashion | Early Stage Venture | 50M | Germany, Karlsruhe, Baden-Württemberg |
| Hainan Zhongle | 28 Feb 2024 | Seed | 773K | Hainan, Haikou, China | |
| Mabwell Biotech | 29 Apr 2020 | Biotechnology, Life Science, Biopharma | Early Stage Venture | 278M | China, Shanghai |
| Pixelleco | 01 Nov 2012 | Artificial Intelligence, Augmented Reality, Virtual Reality, Photography, Digital Media, Video Streaming, Art | Seed | 40K | United States, New York, New York |
| SYNAP6 | 28 Apr 2016 | Health Care, Home Health Care, Elder Care | Seed | 400K | France, Auvergne-Rhône-Alpes, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.